WBP3425 / Wuxi Biocity 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
WBP3425 / Wuxi Biocity
ChiCTR2100045310: A phase 1, open-label, single-center trial to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, preliminary antitumor activity of WBP3425 in patients with advanced solid tumors

Recruiting
1
76
 
0.001mg/kg ;0.003mg/kg ;0.03mg/kg ;0.15mg/kg ;0.5mg/kg ;1.0mg/kg ;2.0mg/kg ;3.0mg/kg ;3.0mg/kg
Shanghai Dongfang Hospital; Wuxi Biocity Biopharmaceutics Co., Ltd., Fully self-raised
Advanced malignant solid tumor
 
 

Download Options